|
Volumn 9, Issue 9, 2004, Pages 1-16
|
Women and anxiety disorders: Implications for diagnosis and treatment
a a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPRAZOLAM;
ANTIDEPRESSANT AGENT;
BUSPIRONE;
FLUOXETINE;
GONADORELIN AGONIST;
HYDROCORTISONE;
OXYTOCIN;
PAROXETINE;
PROLACTIN;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
SEX HORMONE;
THYROID ANTIBODY;
AGORAPHOBIA;
ANXIETY DISORDER;
CLINICAL FEATURE;
COMMUNITY CARE;
COMORBIDITY;
CONFERENCE PAPER;
COPING BEHAVIOR;
DEPRESSION;
DEVELOPED COUNTRY;
DISEASE ASSOCIATION;
DISEASE COURSE;
DRUG EFFICACY;
DRUG MECHANISM;
FEMALE;
FOLLICULAR PHASE;
HEALTH SURVEY;
HORMONE BLOOD LEVEL;
HUMAN;
HYDROCORTISONE BLOOD LEVEL;
HYPOTHYROIDISM;
INJURY;
ISCHEMIC HEART DISEASE;
LIFE CYCLE;
LIFESPAN;
LONG TERM CARE;
LUTEAL PHASE;
MORTALITY;
OBSESSIVE COMPULSIVE DISORDER;
ONSET AGE;
OVULATION;
OXYTOCIN BLOOD LEVEL;
PANIC;
POSTPARTUM ANXIETY;
POSTTRAUMATIC STRESS DISORDER;
PREGNANCY;
PREMENSTRUAL DYSPHORIC DISORDER;
PREVALENCE;
PRIORITY JOURNAL;
PROLACTIN BLOOD LEVEL;
PSYCHOSOCIAL DISORDER;
SEX DIFFERENCE;
SEXUAL CRIME;
SHORT COURSE THERAPY;
STRESS;
THYROIDITIS;
|
EID: 4644263330
PISSN: 10928529
EISSN: None
Source Type: Journal
DOI: 10.1017/s1092852900001978 Document Type: Conference Paper |
Times cited : (29)
|
References (0)
|